Uw zoekopdracht heeft geen resultaten opgeleverd.
We raden u aan het volgende te proberen om te vinden wat u zoekt:
Accelerating site activation can jumpstart a clinical trial, but with the hours and weeks spent manually tracking tasks and documents without visibility into where the bottlenecks lie, how can you make that happen?
Activate Cloud Service enables sponsors, CROs, and sites to get studies started in the shortest time possible. Activate workflows drive study teams to complete and track specific documents and tasks required for any site, country, or study based on regulatory and SOP requirements.
The integration of industry proven study startup workflows with Cognizant's ® Shared Investigator Platform (SIP) accelerates clinical trials by standardizing administrative tasks and processes and bringing about increased efficiencies by minimizing redundant work.
Use visualizations and standardized metrics to aid in the identification of white space and machine learning algorithms to guide optimal timing of parallelization of processes to minimize risks associated with intervention.
Oracle Health Sciences end-to-end study startup solution stood out for the opportunity it provides us to eliminate traditional bottlenecks in the flow of clinical data, which can impact study quality and lead to unnecessary delays.
Learn how trusted collaboration is key to keeping sponsor-CRO partnerships aligned on shared goals.
Learn how the focus on efficiency in ICH E6 (R3) will fundamentally change clinical trials.
Learn how machine learning can help identify and rectify systemic inefficiencies, allowing life science organizations to learn and adapt.
Learn how the collaboration between Cognizant and Oracle eliminates redundancy for sites and deliver better outcomes from sponsors/CROs.
Will the industry embrace this change or revert back to its old ways post-COVID-19?
Learn how vendor oversight can be implemented end-to-end, ensuring compliance with ICH regulation guidelines.
Learn how to gain critical operational insights by using AI/machine learning to transition from subjective decision making.
Learn how digital transformation roadmaps were accelerated to embrace innovative approaches to overcome adversary.
Learn how fundamental to new ICH guidelines is the modernization of processes and technology with a focus on QbD and risk-based management approaches.
Learn how machine learning technologies can help predict outcomes in clinical trials, leading to faster drug approval times and lower costs.
Learn how to overcome the complexities introduced in outsourced studies (e.g., quality, oversight, collaboration, and governance).
Learn how entrenched silos have stymied data flow efforts due to minimal understanding of what is needed downstream.
Activate’s robust, industry proven library of country-specific workflows and management-based approach to site activation is central to our efforts to build out our infrastructure of ‘best of breed’ applications in our eClinical suite.